NAVB

Navidea Biopharmaceuticals Inc.
NAVB

Overview Fund Activity
Delisted

NAVB was delisted on the 5th of October, 2023.

Back to rankings

31 hedge funds and large institutions have $1.68M invested in Navidea Biopharmaceuticals Inc. in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
6
Reduced
7
Closed
3
Calls
$96K
Puts
$379K
Net Calls
-$283K
Net Calls Change
+$86K

Top Buyers

1
Group One Trading
1
Group One Trading
Illinois
$157K
2
Commonwealth Equity Services
2
Commonwealth Equity Services
Massachusetts
$51K
3
VF
3
Virtu Financial
New York
$25K
4
Citadel Advisors
4
Citadel Advisors
Florida
$59K
5
Wolverine Trading
5
Wolverine Trading
Illinois
$13K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
HighTower Advisors
2
HighTower Advisors
Illinois
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$61K
4
Two Sigma Investments
4
Two Sigma Investments
New York
$33K
5
ACM
5
Allred Capital Management
Texas
$53K
Name Holding Trade Value Shares
Change 		Shares
Change %
KFS
26
Kelly Financial Services
Massachusetts
$50 – – –
Susquehanna International Group
27
Susquehanna International Group
Pennsylvania
– -$76K -43,445 Closed
HighTower Advisors
28
HighTower Advisors
Illinois
– -$48K -28,465 Closed
JCM
29
Jacobi Capital Management
Pennsylvania
– -$2K -1,000 Closed
1
2